A recent study demonstrated that inhibition of ubiquitin-specific protease-7 (USP7), which normally stabilizes MDM2, triggers apoptosis in bortezomib-resistant MM cells, confirming the idea of p53 downregulation as a DR mechanism in MM [122]. Here, MDM2 is linked to Miyoshi myopathy.